Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria (Plasmodium Falciparum)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02237586
What this trial is testing

Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge

Who this might be right for
Plasmodium Falciparum MalariaMalaria
Sanaria Inc. 25
Testing effectiveness (Phase 2)Study completedNCT03276962
What this trial is testing

Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age

Who this might be right for
Malaria
GlaxoSmithKline 1,500
Not applicableStudy completedNCT01422954
What this trial is testing

Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis

Who this might be right for
MalariaPlasmodium Falciparum
Radboud University Medical Center 20
Large-scale testing (Phase 3)WithdrawnNCT01082718
What this trial is testing

Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women With Uncomplicated Plasmodium Falciparum Infection

Who this might be right for
MalariaPregnancy
Centers for Disease Control and Prevention
Large-scale testing (Phase 3)Study completedNCT01054248
What this trial is testing

Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy

Who this might be right for
Malaria
University of Oxford 511
Post-approval studies (Phase 4)Not Yet RecruitingNCT07194668
What this trial is testing

R21/MM Dosing, Presentations, and Preservatives

Who this might be right for
Plasmodium Falciparum MalariaMalariaVaccine Reaction
University of Oxford 375
Not applicableStudy completedNCT03281291
What this trial is testing

Study to Assess the Vaccine Efficacy Against Malaria Infection, in Children Immunized With the Primary and Yearly Booster of the RTS,S/AS01E Vaccine, as Part of Their Participation in the Malaria-094 (204889/NCT03276962) Study.

Who this might be right for
Malaria
GlaxoSmithKline 1,500
Early research (Phase 1)Study completedNCT01086917
What this trial is testing

Experimental Human Malaria Infection by PfSPZ

Who this might be right for
Malaria
Sanaria Inc. 18
Not applicableTemporarily pausedNCT01849640
What this trial is testing

Antimalarial Drug Resistance With Assessment of Transmission Blocking Activity

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
David Saunders 150
Not applicableStudy completedNCT05958693
What this trial is testing

TES of Artemether-lumefantrine for Pf in the Philippines in 2015

Who this might be right for
Malaria,FalciparumMalaria Recrudescence
Research Institute for Tropical Medicine, Philippines 82
Large-scale testing (Phase 3)Study completedNCT02699099
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 699
Not applicableStudy completedNCT00757887
What this trial is testing

Re-exposure of EHMI-8 Human Volunteers to Live Malaria Sporozoites

Who this might be right for
P. Falciparum Malaria
Radboud University Medical Center 15
Not applicableWithdrawnNCT04203186
What this trial is testing

A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)

Who this might be right for
Plasmodium Falciparum
U.S. Army Medical Research and Development Command
Testing effectiveness (Phase 2)Study completedNCT00299208
What this trial is testing

Azithromycin Combination Therapy for Malaria

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)Study completedNCT01992900
What this trial is testing

A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Malaria

Who this might be right for
Malaria,Falciparum
sigma-tau i.f.r. S.p.A. 300
Early research (Phase 1)Study completedNCT06735209
What this trial is testing

First-in-Human PfSPZ-LARC2 Vaccination/CHMI

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 22
Post-approval studies (Phase 4)Active Not RecruitingNCT05757167
What this trial is testing

Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics

Who this might be right for
Malaria,FalciparumMalaria in PregnancyMalaria in Childbirth+6 more
Duke University 2,174
Not applicableStudy completedNCT01160562
What this trial is testing

Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity

Who this might be right for
Malaria, FalciparumPlasmodium Falciparum
National Institute of Allergy and Infectious Diseases (NIAID) 1,719
Testing effectiveness (Phase 2)Study completedNCT03660839
What this trial is testing

Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Infection
Sanofi 140
Testing effectiveness (Phase 2)Ended earlyNCT02497612
What this trial is testing

To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Infection
Sanofi 377
Next Page